Q1 2024 Holdings
Filed 2024-05-15 | 112 holdings | $5.7B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-06) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $456.3M | 10,794,876 | 8.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $330.5M | 28,057,456 | 5.8% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $285.6M | 19,272,991 | 5.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $273.6M | 3,933,556 | 4.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $209.0M | 2,783,454 | 3.7% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $148.8M | 4,256,104 | 2.6% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $145.5M | 6,825,395 | 2.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $141.6M | 3,268,579 | 2.5% |
| Apogee Therapeutics Inc(APGE)A | COM | 03770N101 | $136.9M | 2,060,395 | 2.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $132.0M | 1,932,759 | 2.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $131.6M | 3,074,542 | 2.3% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $124.6M | 1,429,563 | 2.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $114.8M | 429,953 | 2.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $111.4M | 2,262,462 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $110.9M | 804,409 | 1.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $97.0M | 2,556,679 | 1.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $95.7M | 2,963,212 | 1.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $94.3M | 1,725,047 | 1.7% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $92.0M | 6,906,646 | 1.6% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $91.2M | 6,485,420 | 1.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $88.2M | 1,105,341 | 1.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $81.5M | 994,098 | 1.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $80.6M | 5,753,798 | 1.4% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $79.4M | 12,757,562 | 1.4% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $77.0M | 3,448,004 | 1.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $73.0M | 1,055,355 | 1.3% |
| Natera Inc(NTRA) | COM | 632307104 | $69.3M | 757,225 | 1.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $69.1M | 1,476,203 | 1.2% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $68.7M | 11,331,103 | 1.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $68.1M | 525,683 | 1.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $64.0M | 3,657,099 | 1.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $60.5M | 3,761,576 | 1.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $58.5M | 939,866 | 1.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $57.3M | 1,304,105 | 1.0% |
| Artivion Inc(AORT) | COM | 228903100 | $56.5M | 2,668,978 | 1.0% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $54.4M | 8,005,000 | 1.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $51.0M | 1,236,603 | 0.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $51.0M | 2,362,279 | 0.9% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $50.1M | 821,589 | 0.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $48.5M | 1,801,068 | 0.8% |
| Immatics N.v(IMTX) | SHS | N44445109 | $48.2M | 4,582,409 | 0.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $47.1M | 1,296,416 | 0.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $43.7M | 1,412,033 | 0.8% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $42.5M | 6,433,369 | 0.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $42.3M | 2,319,646 | 0.7% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $42.0M | 7,099,182 | 0.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $40.6M | 101,800 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $38.4M | 892,208 | 0.7% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $37.0M | 12,594,211 | 0.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $35.0M | 1,387,471 | 0.6% |